第二军医大学学报
第二軍醫大學學報
제이군의대학학보
ACADEMIC JOURNAL OF SECOND MILITARY MEDICAL UNIVERSITY
2004年
1期
75-79
,共5页
薛绪潮%方国恩%张琪%薛惠斌%毕建威%曹贵松%钱其军
薛緒潮%方國恩%張琪%薛惠斌%畢建威%曹貴鬆%錢其軍
설서조%방국은%장기%설혜빈%필건위%조귀송%전기군
增殖型腺病毒载体%白细胞介素12%胃肿瘤%基因疗法
增殖型腺病毒載體%白細胞介素12%胃腫瘤%基因療法
증식형선병독재체%백세포개소12%위종류%기인요법
replication-competent adenovirus%interleukin-12%stomach neoplasms%gene therapy
目的:观察增殖型腺病毒载体介导的mIL-12基因对胃癌细胞的杀伤作用.方法:利用携带mIL-12基因的增殖型腺病毒转染胃癌细胞株SGC-7901,通过病毒增殖实验、细胞病理效应、酶链免疫反应等分别观察病毒复制能力、病毒对胃癌细胞的杀伤作用及mIL-12表达水平.结果:携带mIL-12基因的增殖型腺病毒转染胃癌细胞株SGC-7901具有肿瘤增殖型腺病毒ONYX-015的相似作用,可在肿瘤细胞内复制、增殖并杀死肿瘤细胞,而并不能在正常细胞内复制及增殖.该病毒在肿瘤细胞内的增殖能力是传统载体的近千倍.该载体携带的mIL-12基因的表达量明显高于传统基因治疗的腺病毒载体体系,是传统基因治疗表达量的百倍.结论:CNHK200-mIL-12能在胃癌细胞中增殖并杀死胃癌细胞,并提高目的基因的表达水平,可能为胃癌治疗提供一新途径.
目的:觀察增殖型腺病毒載體介導的mIL-12基因對胃癌細胞的殺傷作用.方法:利用攜帶mIL-12基因的增殖型腺病毒轉染胃癌細胞株SGC-7901,通過病毒增殖實驗、細胞病理效應、酶鏈免疫反應等分彆觀察病毒複製能力、病毒對胃癌細胞的殺傷作用及mIL-12錶達水平.結果:攜帶mIL-12基因的增殖型腺病毒轉染胃癌細胞株SGC-7901具有腫瘤增殖型腺病毒ONYX-015的相似作用,可在腫瘤細胞內複製、增殖併殺死腫瘤細胞,而併不能在正常細胞內複製及增殖.該病毒在腫瘤細胞內的增殖能力是傳統載體的近韆倍.該載體攜帶的mIL-12基因的錶達量明顯高于傳統基因治療的腺病毒載體體繫,是傳統基因治療錶達量的百倍.結論:CNHK200-mIL-12能在胃癌細胞中增殖併殺死胃癌細胞,併提高目的基因的錶達水平,可能為胃癌治療提供一新途徑.
목적:관찰증식형선병독재체개도적mIL-12기인대위암세포적살상작용.방법:이용휴대mIL-12기인적증식형선병독전염위암세포주SGC-7901,통과병독증식실험、세포병리효응、매련면역반응등분별관찰병독복제능력、병독대위암세포적살상작용급mIL-12표체수평.결과:휴대mIL-12기인적증식형선병독전염위암세포주SGC-7901구유종류증식형선병독ONYX-015적상사작용,가재종류세포내복제、증식병살사종류세포,이병불능재정상세포내복제급증식.해병독재종류세포내적증식능력시전통재체적근천배.해재체휴대적mIL-12기인적표체량명현고우전통기인치료적선병독재체체계,시전통기인치료표체량적백배.결론:CNHK200-mIL-12능재위암세포중증식병살사위암세포,병제고목적기인적표체수평,가능위위암치료제공일신도경.
Objective: To investigate antitumor effects of a replication-competent adenovirus carrying mouse interleukin-12 gene on gastric cancer. Methods: Replication-competent adenovirus carrying mouse IL-12 gene (CNHK200-mIL-12) was constructed to transfect gastric carcinoma cell line SGC-7901. The cytopathic effect, the expression of the mouse IL-12 gene, and the replication of the virus were observed respectively by cell pathology, ELISA and virus replication assay. Results: The vector system, CNHK200-mIL-12, possessed the same characteristic as the replicative adenovirus ONYX-015, replicating and proliferating in the gastric carcinoma cells but not in the normal cells, thus specifically killing gastric carcinoma cells. The replication level of CNHK200-mIL-12 in the gastric carcinoma cells was more than one thousand times higher compared with that of the conventional adenovirus vector; the mIL-12 expression level increased by 100 folds compared with that of the conventional adenovirus vector carrying mIL-12 gene. Conclusion: CNHK200-mIL-12 can replicate specifically in gastric carcinoma cells and kill them. Meanwhile, it greatly increases the target gene expression, suggesting that CNHK200-mIL-12 may be used to treat gastric carcinoma.